The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Porcine Heparin APIs Market Research Report 2025
Synopsis
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. The potency of heparin API is the active unit (IU) contained in each milligram (mg) of heparin API. 1 Billion Units=1 Billion IU (International unit). 1Kg is about 0.18-0.22 Billion IU
The global Porcine Heparin APIs market was valued at US$ 1727 million in 2023 and is anticipated to reach US$ 4383 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Although heparin can be synthesized by means of chemical processes, most of the worldwide produced heparin is extracted from animal tissue, porcine intestinal mucosa specifically. The production of heparin is located near the source of raw material. Area’s like China, North America and Europa are the main pork producing areas and these are also the locations of the main heparin producers.
Heparin’s main source, porcine intestinal mucosa, is a by-product of pork slaughtering and is released while cleaning the pork’s casing. Cleaning casings is a specialized process that requires highly skilled staff and state of the art equipment. To avoid degradation of the heparin content and decay, stabilizing agent is added directly after harvesting. The material is stored in bulk tanks awaiting transport to the processing facility. There are also some Bovine-derived APIs on the market, but they are very few, accounting for about 2% to 4% of the global market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Porcine Heparin APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Heparin APIs.
The Porcine Heparin APIs market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Porcine Heparin APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Heparin APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Heparin APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Heparin APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. The potency of heparin API is the active unit (IU) contained in each milligram (mg) of heparin API. 1 Billion Units=1 Billion IU (International unit). 1Kg is about 0.18-0.22 Billion IU
The global Porcine Heparin APIs market was valued at US$ 1727 million in 2023 and is anticipated to reach US$ 4383 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Although heparin can be synthesized by means of chemical processes, most of the worldwide produced heparin is extracted from animal tissue, porcine intestinal mucosa specifically. The production of heparin is located near the source of raw material. Area’s like China, North America and Europa are the main pork producing areas and these are also the locations of the main heparin producers.
Heparin’s main source, porcine intestinal mucosa, is a by-product of pork slaughtering and is released while cleaning the pork’s casing. Cleaning casings is a specialized process that requires highly skilled staff and state of the art equipment. To avoid degradation of the heparin content and decay, stabilizing agent is added directly after harvesting. The material is stored in bulk tanks awaiting transport to the processing facility. There are also some Bovine-derived APIs on the market, but they are very few, accounting for about 2% to 4% of the global market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Porcine Heparin APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Heparin APIs.
The Porcine Heparin APIs market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Porcine Heparin APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Heparin APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Heparin APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Heparin APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Porcine Heparin APIs Market Overview
1.1 Product Definition
1.2 Porcine Heparin APIs by Type
1.2.1 Global Porcine Heparin APIs Market Value Comparison by Type (2024-2030)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Porcine Heparin APIs by Application
1.3.1 Global Porcine Heparin APIs Market Value by Application (2024-2030)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Porcine Heparin APIs Market Size Estimates and Forecasts
1.4.1 Global Porcine Heparin APIs Revenue 2019-2030
1.4.2 Global Porcine Heparin APIs Sales 2019-2030
1.4.3 Global Porcine Heparin APIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Porcine Heparin APIs Market Competition by Manufacturers
2.1 Global Porcine Heparin APIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Porcine Heparin APIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Porcine Heparin APIs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Porcine Heparin APIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Heparin APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Heparin APIs, Product Type & Application
2.7 Global Key Manufacturers of Porcine Heparin APIs, Date of Enter into This Industry
2.8 Global Porcine Heparin APIs Market Competitive Situation and Trends
2.8.1 Global Porcine Heparin APIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Porcine Heparin APIs Players Market Share by Revenue
2.8.3 Global Porcine Heparin APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Porcine Heparin APIs Market Scenario by Region
3.1 Global Porcine Heparin APIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Porcine Heparin APIs Sales by Region: 2019-2030
3.2.1 Global Porcine Heparin APIs Sales by Region: 2019-2024
3.2.2 Global Porcine Heparin APIs Sales by Region: 2025-2030
3.3 Global Porcine Heparin APIs Revenue by Region: 2019-2030
3.3.1 Global Porcine Heparin APIs Revenue by Region: 2019-2024
3.3.2 Global Porcine Heparin APIs Revenue by Region: 2025-2030
3.4 North America Porcine Heparin APIs Market Facts & Figures by Country
3.4.1 North America Porcine Heparin APIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Porcine Heparin APIs Sales by Country (2019-2030)
3.4.3 North America Porcine Heparin APIs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Porcine Heparin APIs Market Facts & Figures by Country
3.5.1 Europe Porcine Heparin APIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Porcine Heparin APIs Sales by Country (2019-2030)
3.5.3 Europe Porcine Heparin APIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Heparin APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Porcine Heparin APIs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Porcine Heparin APIs Sales by Region (2019-2030)
3.6.3 Asia Pacific Porcine Heparin APIs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Porcine Heparin APIs Market Facts & Figures by Country
3.7.1 Latin America Porcine Heparin APIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Porcine Heparin APIs Sales by Country (2019-2030)
3.7.3 Latin America Porcine Heparin APIs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Porcine Heparin APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Heparin APIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Porcine Heparin APIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Porcine Heparin APIs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Heparin APIs Sales by Type (2019-2030)
4.1.1 Global Porcine Heparin APIs Sales by Type (2019-2024)
4.1.2 Global Porcine Heparin APIs Sales by Type (2025-2030)
4.1.3 Global Porcine Heparin APIs Sales Market Share by Type (2019-2030)
4.2 Global Porcine Heparin APIs Revenue by Type (2019-2030)
4.2.1 Global Porcine Heparin APIs Revenue by Type (2019-2024)
4.2.2 Global Porcine Heparin APIs Revenue by Type (2025-2030)
4.2.3 Global Porcine Heparin APIs Revenue Market Share by Type (2019-2030)
4.3 Global Porcine Heparin APIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Porcine Heparin APIs Sales by Application (2019-2030)
5.1.1 Global Porcine Heparin APIs Sales by Application (2019-2024)
5.1.2 Global Porcine Heparin APIs Sales by Application (2025-2030)
5.1.3 Global Porcine Heparin APIs Sales Market Share by Application (2019-2030)
5.2 Global Porcine Heparin APIs Revenue by Application (2019-2030)
5.2.1 Global Porcine Heparin APIs Revenue by Application (2019-2024)
5.2.2 Global Porcine Heparin APIs Revenue by Application (2025-2030)
5.2.3 Global Porcine Heparin APIs Revenue Market Share by Application (2019-2030)
5.3 Global Porcine Heparin APIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Company Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shenzhen Hepalink Pharmaceutical Porcine Heparin APIs Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Company Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yantai Dongcheng Pharmaceutical Porcine Heparin APIs Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Porcine Heparin APIs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bioibérica
6.4.1 Bioibérica Company Information
6.4.2 Bioibérica Description and Business Overview
6.4.3 Bioibérica Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bioibérica Porcine Heparin APIs Product Portfolio
6.4.5 Bioibérica Recent Developments/Updates
6.5 Changzhou Qianhong Biopharma
6.5.1 Changzhou Qianhong Biopharma Company Information
6.5.2 Changzhou Qianhong Biopharma Description and Business Overview
6.5.3 Changzhou Qianhong Biopharma Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changzhou Qianhong Biopharma Porcine Heparin APIs Product Portfolio
6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.6 Nanjing King-friend Biochemical Pharmaceutical
6.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
6.6.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 Nanjing King-friend Biochemical Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanjing King-friend Biochemical Pharmaceutical Porcine Heparin APIs Product Portfolio
6.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.7.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hebei Changshan Biochemical Pharmaceutical Porcine Heparin APIs Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Company Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qingdao Jiulong Biopharmaceutical Porcine Heparin APIs Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Opocrin Porcine Heparin APIs Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Company Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dongying Tiandong Pharmaceutical Porcine Heparin APIs Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Company Information
6.11.2 Aspen Oss Description and Business Overview
6.11.3 Aspen Oss Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Aspen Oss Porcine Heparin APIs Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Company Information
6.12.2 Yino Pharma Description and Business Overview
6.12.3 Yino Pharma Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yino Pharma Porcine Heparin APIs Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Nanjing Xinbai Pharmaceutical
6.13.1 Nanjing Xinbai Pharmaceutical Company Information
6.13.2 Nanjing Xinbai Pharmaceutical Description and Business Overview
6.13.3 Nanjing Xinbai Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nanjing Xinbai Pharmaceutical Porcine Heparin APIs Product Portfolio
6.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.14 Hubei Enoray Biopharmaceutical
6.14.1 Hubei Enoray Biopharmaceutical Company Information
6.14.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.14.3 Hubei Enoray Biopharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hubei Enoray Biopharmaceutical Porcine Heparin APIs Product Portfolio
6.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Company Information
6.15.2 Cisen Pharmaceutical Description and Business Overview
6.15.3 Cisen Pharmaceutical Porcine Heparin APIs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cisen Pharmaceutical Porcine Heparin APIs Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Heparin APIs Industry Chain Analysis
7.2 Porcine Heparin APIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Heparin APIs Production Mode & Process
7.4 Porcine Heparin APIs Sales and Marketing
7.4.1 Porcine Heparin APIs Sales Channels
7.4.2 Porcine Heparin APIs Distributors
7.5 Porcine Heparin APIs Customers
8 Porcine Heparin APIs Market Dynamics
8.1 Porcine Heparin APIs Industry Trends
8.2 Porcine Heparin APIs Market Drivers
8.3 Porcine Heparin APIs Market Challenges
8.4 Porcine Heparin APIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Porcine Heparin APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Porcine Heparin APIs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Porcine Heparin APIs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Porcine Heparin APIs Sales (Billion Units) of Key Manufacturers (2019-2024)
Table 5. Global Porcine Heparin APIs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Porcine Heparin APIs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Porcine Heparin APIs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Porcine Heparin APIs Average Price (US$/Billion Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Porcine Heparin APIs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Porcine Heparin APIs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Heparin APIs, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Heparin APIs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Heparin APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Heparin APIs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Heparin APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Porcine Heparin APIs Sales by Region (2019-2024) & (Billion Units)
Table 18. Global Porcine Heparin APIs Sales Market Share by Region (2019-2024)
Table 19. Global Porcine Heparin APIs Sales by Region (2025-2030) & (Billion Units)
Table 20. Global Porcine Heparin APIs Sales Market Share by Region (2025-2030)
Table 21. Global Porcine Heparin APIs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Porcine Heparin APIs Revenue Market Share by Region (2019-2024)
Table 23. Global Porcine Heparin APIs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Porcine Heparin APIs Revenue Market Share by Region (2025-2030)
Table 25. North America Porcine Heparin APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Porcine Heparin APIs Sales by Country (2019-2024) & (Billion Units)
Table 27. North America Porcine Heparin APIs Sales by Country (2025-2030) & (Billion Units)
Table 28. North America Porcine Heparin APIs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Porcine Heparin APIs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Porcine Heparin APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Porcine Heparin APIs Sales by Country (2019-2024) & (Billion Units)
Table 32. Europe Porcine Heparin APIs Sales by Country (2025-2030) & (Billion Units)
Table 33. Europe Porcine Heparin APIs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Porcine Heparin APIs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Porcine Heparin APIs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Porcine Heparin APIs Sales by Region (2019-2024) & (Billion Units)
Table 37. Asia Pacific Porcine Heparin APIs Sales by Region (2025-2030) & (Billion Units)
Table 38. Asia Pacific Porcine Heparin APIs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Porcine Heparin APIs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Porcine Heparin APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Porcine Heparin APIs Sales by Country (2019-2024) & (Billion Units)
Table 42. Latin America Porcine Heparin APIs Sales by Country (2025-2030) & (Billion Units)
Table 43. Latin America Porcine Heparin APIs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Porcine Heparin APIs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Porcine Heparin APIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Porcine Heparin APIs Sales by Country (2019-2024) & (Billion Units)
Table 47. Middle East and Africa Porcine Heparin APIs Sales by Country (2025-2030) & (Billion Units)
Table 48. Middle East and Africa Porcine Heparin APIs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Porcine Heparin APIs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Porcine Heparin APIs Sales (Billion Units) by Type (2019-2024)
Table 51. Global Porcine Heparin APIs Sales (Billion Units) by Type (2025-2030)
Table 52. Global Porcine Heparin APIs Sales Market Share by Type (2019-2024)
Table 53. Global Porcine Heparin APIs Sales Market Share by Type (2025-2030)
Table 54. Global Porcine Heparin APIs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Porcine Heparin APIs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Porcine Heparin APIs Revenue Market Share by Type (2019-2024)
Table 57. Global Porcine Heparin APIs Revenue Market Share by Type (2025-2030)
Table 58. Global Porcine Heparin APIs Price (US$/Billion Units) by Type (2019-2024)
Table 59. Global Porcine Heparin APIs Price (US$/Billion Units) by Type (2025-2030)
Table 60. Global Porcine Heparin APIs Sales (Billion Units) by Application (2019-2024)
Table 61. Global Porcine Heparin APIs Sales (Billion Units) by Application (2025-2030)
Table 62. Global Porcine Heparin APIs Sales Market Share by Application (2019-2024)
Table 63. Global Porcine Heparin APIs Sales Market Share by Application (2025-2030)
Table 64. Global Porcine Heparin APIs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Porcine Heparin APIs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Porcine Heparin APIs Revenue Market Share by Application (2019-2024)
Table 67. Global Porcine Heparin APIs Revenue Market Share by Application (2025-2030)
Table 68. Global Porcine Heparin APIs Price (US$/Billion Units) by Application (2019-2024)
Table 69. Global Porcine Heparin APIs Price (US$/Billion Units) by Application (2025-2030)
Table 70. Shenzhen Hepalink Pharmaceutical Company Information
Table 71. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 72. Shenzhen Hepalink Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 73. Shenzhen Hepalink Pharmaceutical Porcine Heparin APIs Product
Table 74. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 75. Yantai Dongcheng Pharmaceutical Company Information
Table 76. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 77. Yantai Dongcheng Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 78. Yantai Dongcheng Pharmaceutical Porcine Heparin APIs Product
Table 79. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 83. Pfizer Porcine Heparin APIs Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Bioibérica Company Information
Table 86. Bioibérica Description and Business Overview
Table 87. Bioibérica Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 88. Bioibérica Porcine Heparin APIs Product
Table 89. Bioibérica Recent Developments/Updates
Table 90. Changzhou Qianhong Biopharma Company Information
Table 91. Changzhou Qianhong Biopharma Description and Business Overview
Table 92. Changzhou Qianhong Biopharma Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 93. Changzhou Qianhong Biopharma Porcine Heparin APIs Product
Table 94. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 95. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 96. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 97. Nanjing King-friend Biochemical Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 98. Nanjing King-friend Biochemical Pharmaceutical Porcine Heparin APIs Product
Table 99. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 101. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 102. Hebei Changshan Biochemical Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 103. Hebei Changshan Biochemical Pharmaceutical Porcine Heparin APIs Product
Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 105. Qingdao Jiulong Biopharmaceutical Company Information
Table 106. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 107. Qingdao Jiulong Biopharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 108. Qingdao Jiulong Biopharmaceutical Porcine Heparin APIs Product
Table 109. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 110. Opocrin Company Information
Table 111. Opocrin Description and Business Overview
Table 112. Opocrin Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 113. Opocrin Porcine Heparin APIs Product
Table 114. Opocrin Recent Developments/Updates
Table 115. Dongying Tiandong Pharmaceutical Company Information
Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 117. Dongying Tiandong Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 118. Dongying Tiandong Pharmaceutical Porcine Heparin APIs Product
Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 120. Aspen Oss Company Information
Table 121. Aspen Oss Description and Business Overview
Table 122. Aspen Oss Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 123. Aspen Oss Porcine Heparin APIs Product
Table 124. Aspen Oss Recent Developments/Updates
Table 125. Yino Pharma Company Information
Table 126. Yino Pharma Description and Business Overview
Table 127. Yino Pharma Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 128. Yino Pharma Porcine Heparin APIs Product
Table 129. Yino Pharma Recent Developments/Updates
Table 130. Nanjing Xinbai Pharmaceutical Company Information
Table 131. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 132. Nanjing Xinbai Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 133. Nanjing Xinbai Pharmaceutical Porcine Heparin APIs Product
Table 134. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
Table 135. Hubei Enoray Biopharmaceutical Company Information
Table 136. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 137. Hubei Enoray Biopharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 138. Hubei Enoray Biopharmaceutical Porcine Heparin APIs Product
Table 139. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 140. Cisen Pharmaceutical Company Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Porcine Heparin APIs Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)
Table 143. Cisen Pharmaceutical Porcine Heparin APIs Product
Table 144. Cisen Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Porcine Heparin APIs Distributors List
Table 148. Porcine Heparin APIs Customers List
Table 149. Porcine Heparin APIs Market Trends
Table 150. Porcine Heparin APIs Market Drivers
Table 151. Porcine Heparin APIs Market Challenges
Table 152. Porcine Heparin APIs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Porcine Heparin APIs
Figure 2. Global Porcine Heparin APIs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Porcine Heparin APIs Market Share by Type: 2023 & 2030
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Porcine Heparin APIs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Porcine Heparin APIs Market Share by Application: 2023 & 2030
Figure 8. UFH
Figure 9. LMWH
Figure 10. Global Porcine Heparin APIs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Porcine Heparin APIs Market Size (2019-2030) & (US$ Million)
Figure 12. Global Porcine Heparin APIs Sales (2019-2030) & (Billion Units)
Figure 13. Global Porcine Heparin APIs Average Price (US$/Billion Units) & (2019-2030)
Figure 14. Porcine Heparin APIs Report Years Considered
Figure 15. Porcine Heparin APIs Sales Share by Manufacturers in 2023
Figure 16. Global Porcine Heparin APIs Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest Porcine Heparin APIs Players: Market Share by Revenue in Porcine Heparin APIs in 2023
Figure 18. Porcine Heparin APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Porcine Heparin APIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Porcine Heparin APIs Sales Market Share by Country (2019-2030)
Figure 21. North America Porcine Heparin APIs Revenue Market Share by Country (2019-2030)
Figure 22. United States Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Porcine Heparin APIs Sales Market Share by Country (2019-2030)
Figure 25. Europe Porcine Heparin APIs Revenue Market Share by Country (2019-2030)
Figure 26. Germany Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Porcine Heparin APIs Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Porcine Heparin APIs Revenue Market Share by Region (2019-2030)
Figure 33. China Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Porcine Heparin APIs Sales Market Share by Country (2019-2030)
Figure 41. Mexico Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Brazil Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Argentina Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Colombia Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East and Africa Porcine Heparin APIs Sales Market Share by Country (2019-2030)
Figure 46. Middle East and Africa Porcine Heparin APIs Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Porcine Heparin APIs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Porcine Heparin APIs by Type (2019-2030)
Figure 51. Global Revenue Market Share of Porcine Heparin APIs by Type (2019-2030)
Figure 52. Global Porcine Heparin APIs Price (US$/Billion Units) by Type (2019-2030)
Figure 53. Global Sales Market Share of Porcine Heparin APIs by Application (2019-2030)
Figure 54. Global Revenue Market Share of Porcine Heparin APIs by Application (2019-2030)
Figure 55. Global Porcine Heparin APIs Price (US$/Billion Units) by Application (2019-2030)
Figure 56. Porcine Heparin APIs Value Chain
Figure 57. Porcine Heparin APIs Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
